Evidence map›Paper›PMID 21146468›Full record

Trial reportThe journal of pain2011

Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome.

QiQi Zhou, Donald D Price, Christopher S Callam, Michael A Woodruff, G Nicholas Verne

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The journal of pain, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Epigenetic modulation of visceral nociception.Neurogastroenterology and motility · 2022
    Review
  9. Article
  10. Article
  11. Spinal neuron-glia-immune interaction in cross-organ sensitization.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Phenotypic Features of Central Sensitization.Journal of applied biobehavioral research · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

QiQi ZhouDepartment of Medicine, The Ohio State University, Columbus, Ohio, USA.
Donald D Price
Christopher S Callam
Michael A Woodruff
G Nicholas Verne
The Ohio State University · USCincinnati VA Medical Center · USFlorida College · US

Funding

Mechanisms of Central and Peripheral HyperalgesiaR01NS053090 · NINDS · UNIVERSITY OF FLORIDA · PI VERNE, GEORGE NICHOLAS · 2005 to 2008
$1.3M
Randomized Placebo-Controlled Trial of Glutamine for Patients with IBSR21AT005291 · NCCIH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI VERNE, GEORGE NICHOLAS · 2010 to 2012
$566k
NCCIH NIH HHS R21 AT005291NINDS NIH HHS R01 NS053090NINDS NIH HHS R01-NS053090
6 · The paper itself

Abstract

unlabelledIrritable bowel syndrome (IBS) is a common gastrointestinal disorder in which the pathophysiological mechanisms of the pain and hypersensitivity are not well understood. IBS patients frequently complain of pain in body regions somatotopically distinct from the gut, suggesting that central hyperalgesic mechanisms may be involved. In the current study, during the wind-up testing session, a series of 6 heat pulses were presented with an interstimulus interval (ISI) of 3 seconds. Following the 1st, 3rd, and 6th thermal stimuli, subjects were asked to rate the late thermal sensation or second pain. IBS patients who demonstrated temporal summation of pain (TSSP) then received dextromethorphan and placebo in a randomized, double-blind, fashion to block wind-up. The results showed: 1) a subset of IBS patients, but not controls, showed TSSP in response to a series of noxious heat pulses; and 2) TSSP was blocked by administration of dextromethorphan, an NMDA receptor antagonist. In summary, these findings further elucidate mechanisms of somatic hypersensitivity in a subset of IBS patients. Our results also support an etiologic basis for abnormal NMDA receptor mechanisms in some IBS patients. Future studies are needed to determine if NMDA receptor antagonists may be used to treat IBS patients. PERSPECTIVE: This study evaluates temporal summation of second pain in a subset of IBS patients that is blocked by Dextromethorphan, an NMDA receptor antagonist. Theses results could lead to the use of an NMDA receptor antagonist in the treatment of pain in a subset of IBS patients.

Indexed as

AdultDextromethorphanDouble-Blind MethodExcitatory Amino Acid AntagonistsFemaleGlutamic AcidHumansHyperalgesiaIrritable Bowel SyndromeMaleNociceptorsPain MeasurementPain ThresholdReceptors, N-Methyl-D-AspartateSynaptic TransmissionDextromethorphanExcitatory Amino Acid AntagonistsGlutamic AcidReceptors, N-Methyl-D-Aspartate

Identifiers

PMID21146468
PMCPMC3058359
OpenAlexW2086989364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.